Latest News and Press Releases
Want to stay updated on the latest news?
- 
                            
Ottawa, Nov. 03, 2025 (GLOBE NEWSWIRE) -- According to Statifacts, the global cell therapy raw materials market size was valued at USD 4,690 million in 2024 and is predicted to be worth around USD...
 - 
                            
Ottawa, Oct. 30, 2025 (GLOBE NEWSWIRE) -- According to Statifacts, the global car t-cell therapy market size reached USD 5.51 billion in 2024 and is estimated to attain USD 146.55 billion by 2034,...
 - 
                            
NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies...
 - 
                            Tevogen Senior Management Engages with Business and Community Leaders and Highlights Recent Progress
WARREN, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), in ongoing community, industry, and academic engagements, has continued to...
 - 
                            
AACHEN, Germany, Oct. 28, 2025 (GLOBE NEWSWIRE) -- PL BioScience GmbH, a German life science company specializing in the production and development of Human Platelet Lysate (HPL) for cell expansion...
 - 
                            
Austin, Oct. 27, 2025 (GLOBE NEWSWIRE) -- CAR T-Cell Therapies Market Size & Growth Analysis According to SNS Insider, the global CAR T-Cell Therapies Market was valued at USD 5.42 billion in...
 - 
                            
Houston, Texas and Tuebingen, Germany, October 27, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company and the global leader in precision...
 - 
                            
Austin, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Cell Banking Outsourcing Market Size & Growth Analysis: According to SNS Insider, the Cell Banking Outsourcing Market is valued at USD 12.5 billion...
 - 
                            
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to...
 - 
                            
SINGAPORE, Oct. 22, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing...